Building Science-Driven Startups.
Accelerating Nascent Technologies.
We design, develop, and scale science-driven startups while advancing biomedical technologies from early-stage concept through clinical validation to commercialization.
Weidu Investment (WDI) partners with visionary entrepreneurs to translate groundbreaking life sciences innovations into tangible healthcare impact. Our mission is grounded in the rigorous pursuit of novel, evidence-based solutions to pressing global health challenges.
A Specialized Healthcare Venture Fund Anchored in Objective Scientific Evidence
Since its founding in 2008, Weidu Investment (WDI) has maintained an exclusive focus on life sciences and healthcare innovation—specifically the discovery, development, and delivery of transformative therapeutics and vaccines. Our team comprises seasoned scientists, engineers, regulatory experts, and entrepreneurs, united by a commitment to advancing human health through rigorous science, clinical insight, and translational discipline.
Leveraging decades of integrated experience across target identification, preclinical development, global clinical trial execution, regulatory strategy (FDA/EMA/NMPA), health economics and outcomes research (HEOR), and commercialisation, WDI delivers strategic, stage-gated partnership to founders—from concept validation and venture lab acceleration through pivotal clinical development and toward sustainable market access.
We are a specialized healthcare venture fund that invests selectively in scientifically de-risked, patient-centred innovations with strong biological rationale, robust preclinical or early clinical evidence, and clear pathways to regulatory approval and meaningful health impact.
Full Value Chain Support
Beyond capital, we provide deep operational support across the full biopharmaceutical value chain: optimizing candidate selection, strengthening clinical development plans, navigating complex regulatory landscapes, designing payer-aligned evidence strategies, and preparing for scalable commercial launch.
Our Mission
“What primarily drives us is the relentless pursuit of innovative solutions for the daunting tasks of modern-day healthcare.”
Advancing Global Health Through Innovation
We drive the translation of breakthrough scientific insights into clinically meaningful solutions that address critical unmet medical needs and improve health outcomes worldwide.
Strategic Partner in Health Innovation
We collaborate with visionary entrepreneurs, academic institutions, industry leaders, and—critically—with patients and patient communities to co-develop and accelerate transformative solutions.
Championing Patient-Centered Innovation
Our investment strategy integrates patient perspectives, lived experience, and outcome priorities throughout the development lifecycle to ensure clinical benefit and real-world alignment across the continuum of care.
Our Approach
Investing in Visionary Entrepreneurs and Transformative Technologies
We prioritize founders who demonstrate technical vision, strategic acumen, operational rigor, and adaptive capacity required to translate innovation into clinical utility and sustainable value.
Building High-Performance Biomedical Startups
We systematically assemble and integrate cutting-edge technologies, domain-specific talent, and strategic capital to establish startups capable of navigating scientific, regulatory, and commercial complexities.
Cultivating Innovation and Organizational Excellence
Beyond capital deployment, we provide strategic guidance, operational mentorship, and functional expertise across R&D, clinical development, regulatory affairs, and commercialization.
Accelerating Therapeutic Development Through Strategic Alliances
We proactively support portfolio companies in identifying and executing high-impact strategic partnerships with academic medical centers, CDMOs, biopharma leaders, and global payers.
Management & Investment Team
Proven leadership across drug discovery, clinical medicine, corporate finance, and international venture building.
WEI WANG PhD
WEI LI MBA
HAISHAN XIONG PhD
EMMANUEL LAWRENCE
PENG ZHANG PhD
SHIJUN XING CPA
AOXUE WANG MD PhD
YU KONG LLM
Submit Your Investment Pitch
Accelerate your funding request and ensure timely completion. (* Indicates required field)
Contact
HK
Offshore Base
WEIDU INVESTMENT (HK) CO., LTD.
Flat A, 19/F Man King Building
9-11 Bonham Strand West, Sheung Wan
Hong Kong
DALIAN
Headquarters
DALIAN WEIDU INVESTMENT CO., LTD.
17 Songlan Street, Jinpu New Area
Dalian City, Liaoning, China
SHENZHEN
Branch Office
SHENZHEN OFFICE
22F NanGuo Building, Hongling Middle Road
Shenzhen City, Guangdong, China